Insights

Gathering insights about Exo…

Similar companies to Exo

Exo Tech Stack

Exo uses 8 technology products and services including Microsoft Advertising, CUDA, Veeam, and more. Explore Exo's tech stack below.

Microsoft Advertising
Advertising
CUDA
Audio, Video, Graphics
Veeam
Backup And Recovery
Wix
Content Management System
NoSQL
Database
Envoy
Load Balancers
Appium
Testing And Qa
LabVIEW
Visualisation Software

Media & News

eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
LOS ANGELES, CA / ACCESS Newswire / May 7, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into nutraceuticals, novel medicines, and valuable chemicals - announced its graduation from the Shell GameChanger™ Accelerator, a multimillion-dollar, multiyear program developed in collaboration between Shell and the U.S. Department of Energy's National Laboratory of the Rockies (NLR). From 2023 to 2026, eXoZymes partnered with GCxN to advance the next generation of transformative technologies with the potential to dramatically alter the future global energy landscape.
May 07, 2026 | www.accessnewswire.com
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
LOS ANGELES, CA / ACCESS Newswire / April 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced that Chief Commercial Officer, Damien Perriman was featured on the latest episode of the industry leading Grow Everything podcast to discuss the company's first spinout, NCTx, and how eXoZymes is building a repeatable commercialization model for high-value natural products. The Grow Everything podcast is co-hosted by biotech experts, Erum Azeez Khan and Karl Schmieder.
Apr 10, 2026 | www.accessnewswire.com
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
Management to Host Conference Call Today at 5:30 PM Eastern LOS ANGELES, CA / ACCESS Newswire / March 31, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - provides an update on operations through the fiscal year ended December 31, 2025. Michael Heltzen, CEO of eXoZymes, states, "We've moved beyond our ‘big idea' potential and into execution - building differentiated assets and capabilities in a capital-efficient way that we believe sets us apart.
Mar 31, 2026 | www.accessnewswire.com
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
LOS ANGELES, CA / ACCESS Newswire / March 25, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced the plan to host a webinar on Tuesday, March 31, 2026 at 5:30 PM Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing these results will be issued prior to the call.
Mar 25, 2026 | www.accessnewswire.com
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
LOS ANGELES, CA / ACCESS Newswire / March 18, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced an important validation and de-risking milestone for its cell-free biomanufacturing platform: An independent partner, Cayman Chemical, successfully ran eXoZymes' technology at pilot scale and achieved results consistent with - and in some cases exceeding - earlier internal runs. Using eXoZymes' tech transfer package, Cayman Chemical advanced the protocol from a one-liter setup to a 100-liter pilot run, operating the reaction, downstream processing, and analysis independently.
Mar 18, 2026 | www.accessnewswire.com
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
LOS ANGELES, CA / ACCESS Newswire / March 12, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines - announced that Perriman will present a solution for scaling production of NCT, a naturally occurring small molecule currently being developed by eXoZymes for both nutraceutical and pharmaceutical applications. The presentation will focus on NCT's potential role in metabolic health and its emerging relevance in the rapidly evolving landscape of food, supplements, and longevity-focused wellness solutions.
Mar 12, 2026 | www.accessnewswire.com
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS)
eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. Insider and Institutional Ownership 30.0% of Curis shares are
Mar 05, 2026 | www.defenseworld.net

Exo's Email Address Formats

Exo uses at least 2 format(s):

Exo Email Formats	Example	Percentage
FLast@exo-imaging.com	JDoe@exo-imaging.com	73%
First@exo-imaging.com	John@exo-imaging.com	24%
First.Last@exo-imaging.com	John.Doe@exo-imaging.com	2%
F_Last@exo-imaging.com	J_Doe@exo-imaging.com	1%
FLast@exo.inc	JDoe@exo.inc	77%
Last@exo.inc	Doe@exo.inc	23%

Frequently Asked Questions

Where is Exo's headquarters located?

Exo's main headquarters is located at 4201 Burton Drive Santa Clara, California 95054 United States. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Exo's stock symbol?

Exo is a publicly traded company; the company's stock symbol is EXOZ.

What is Exo's official website and social media links?

Exo's official website is exo.inc and has social profiles on LinkedIn.

What is Exo's NAICS code?

Exo's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Exo have currently?

As of April 2026, Exo has approximately 190 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Vice President Of Manufacturing: J. C.Vice President Organizational Development: A. T.Head Of International Sales, Distribution & Strategic Partnerships: A. S.. Explore Exo's employee directory with LeadIQ.

What industry does Exo belong to?

Exo operates in the Medical Equipment Manufacturing industry.

What technology does Exo use?

Exo's tech stack includes Microsoft AdvertisingCUDAVeeamWixNoSQLEnvoyAppiumLabVIEW.

What is Exo's email format?

Exo's email format typically follows the pattern of FLast@exo-imaging.com. Find more Exo email formats with LeadIQ.

When was Exo founded?

Exo was founded in 2015.

Exo

Q: What is Exo's official website and social media links?

Exo's official website is exo.inc. Exo has social profiles on LinkedIn.

Q: How many employees does Exo have currently?

Exo has approximately 190 employees.

Q: What technology does Exo use?

Exo's tech stack includes C#, Google Data Studio, Google Tag Manager, Cloudflare Bot Management, Crazy Egg.

Q: What is Exo's NAICS code?

Exo's NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

Exo (pronounced “Echo”) is a medical imaging software and devices company. Exo believes everyone around the world should have access to high-quality, affordable and easy-to-use medical imaging. The company is on a mission to modernize medical imaging through its high-performance ultrasound platform and artificial intelligence. Exo’s goal is to enable healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes.

Our powerful ecosystem combines high-performance imaging, FDA-cleared AI and workflow software that's designed to make medical imaging as simple as using a smartphone.